Syndecan-1, a new target molecule involved in progression of androgen-independent prostate cancer

Cancer Science

Volumn 100, Issue 7, 2009, Pages 1248-1254

  Shimada, Keiji ^a   Nakamura, Mitsutoshi ^a   De Velasco, Marco A ^a   Tanaka, Motoyoshi ^a   Ouji, Yukiteru ^b   Konishi, Noboru ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ATELOCOLLAGEN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SMALL INTERFERING RNA; SYNDECAN 1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL LINE DU 145; CANCER CELL LINE PC 3; CANCER GROWTH; CANCER HORMONE THERAPY; CARCINOGENESIS; CELL STRAIN LNCAP; CELL SURVIVAL; CHORIOALLANTOIS; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INOCULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR CELL CULTURE; TUMOR VOLUME; UPREGULATION;

ANDROGENS; ANIMALS; CELL LINE, TUMOR; HUMANS; MALE; MICE; MICE, NUDE; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; SYNDECAN-1; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 67449097525     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01174.x     Document Type: Article

References (30)

1. Bernfield M, Gotte M, Park PW et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68: 729-77.
2. Dhodapkar MV, Abe E, Theus A et al. Syndecan-1 is a multifunctional regulator of myeloma pathobiology: Control of tumor cell survival, growth, and bone cell differentiation. Blood 1998; 91: 2679-88.
3. Wijdenes J, Vooijs WC, Clement C et al. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br J Haematol 1996; 94: 318-23.
4. Mahtouk K, Cremer FW, Reme T et al. Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma. Oncogene 2006; 25: 7180-91.
5. Derksen PW, Keehnen RM, Evers LM, van Oers MH, Spaargaren M, Pals ST. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. Blood 2002; 99: 1405-10.
6. Kragh M, Loechel F. Non-anti-coagulant heparins: A promising approach for prevention of tumor metastasis (review). Int J Oncol 2005; 27: 1159-67.
7. Yang Y, MacLeod V, Dai Y et al. The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy. Blood 2007; 110: 2041-8.
8. 2 for platelet-derived growth factor signal transduction. Science 1995; 270: 296-9.
9. Shibanuma M, Arata S, Murata M, Nose K. Activation of DNA synthesis and expression of the JE gene by catalase in mouse osteoblastic cells: possible involvement of hydrogen peroxide in negative growth regulation. Exp Cell Res 1995; 218: 132-6.
10. Doudican NA, Song B, Shadel GS, Doetsch PW. Oxidative DNA damage causes mitochondrial genomic instability in Saccharomyces cerevisiae. Mol Cell Biol 2005; 25: 5196-204.
11. Irani K, Xia Y, Zweier JL et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997; 275: 1649-52.
12. Babior BM. The respiratory burst oxidase. Curr Opin Hematol 1995; 2: 55-60.
13. Segal AW, Shatwell KP. The NADPH oxidase of phagocytic leukocytes. Ann N Y Acad Sci 1997; 832: 215-22.
14. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004; 4: 181-9.
15. Shimada K, Nakamura M, Ishida E et al. Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer. Cancer Sci 2008; 99: 39-45.
16. Bae YS, Kang SW, Seo MS et al. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 1997; 272: 217-21.
17. Tsujikawa K, Koike K, Kitae K et al. Expression and sub-cellular localization of human ABH family molecules. J Cell Mol Med 2007; 11: 1105-16.
18. Singh RP, Tyagi A, Sharma G, Mohan S, Agarwal R. Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin. Clin Cancer Res 2008; 14: 300-8.
19. Shimada K, Matsuyoshi S, Nakamura M, Ishida E, Konishi N. Phosphorylation status of Fas-associated death domain-containing protein (FADD) is associated with prostate cancer progression. J Pathol 2005; 206: 423-32.
20. Konishi N, Nakamura M, Kishi M, Nishimine M, Ishida E, Shimada K. Heterogeneous methylation and deletion patterns of the INK4a/ARF locus within prostate carcinomas. Am J Pathol 2002; 160: 1207-14.
21. Shimada K, Nakamura M, Ishida E et al. c-Jun NH2 terminal kinase activation and decreased expression of mitogen-activated protein kinase phosphatase-1 play important roles in invasion and angiogenesis of urothelial carcinomas. Am J Pathol 2007; 171: 1003-12.
22. Singh RP, Mallikarjuna GU, Sharma G et al. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance. Clin Cancer Res 2004; 10: 8641-7.
23. Singh RP, Deep G, Chittezhath M et al. Effect of silibinin on the growth and progression of primary lung tumors in mice. J Natl Cancer Inst 2006; 98: 846-55.
24. Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 2008; 68: 1777-85.
25. Azzali G. Tumor cell transendothelial passage in the absorbing lymphatic vessel of transgenic adenocarcinoma mouse prostate. Am J Pathol 2007; 170: 334-46.
26. Xia C, Meng Q, Liu LZ, Rojanasakul Y, Wang XR, Jiang BH. Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res 2007; 67: 10 823-30.
27. Komatsu D, Kato M, Nakayama J, Miyagawa S, Kamata T. NADPH oxidase 1 plays a critical mediating role in oncogenic Ras-induced vascular endothelial growth factor expression. Oncogene 2008; 27: 4724-32.
28. Abid MR, Spokes KC, Shih SC, Aird WC. NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways. J Biol Chem 2007; 282: 35 373-85.
29. Rapraeger AC. Syndecan-regulated receptor signaling. J Cell Biol 2000; 149: 995-8.
30. Couchman JR. Syndecans. proteoglycan regulators of cell-surface microdomains? Nature Rev 2003; 4: 926-37.